Filing Details
- Accession Number:
- 0000939767-20-000072
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-08 21:14:31
- Reporting Period:
- 2020-05-07
- Accepted Time:
- 2020-05-08 21:14:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 939767 | Exelixis Inc. | EXEL | Services-Commercial Physical & Biological Research (8731) | 043257395 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1326377 | B Carl Feldbaum | C/O Exelixis, Inc. 1851 Harbor Bay Parkway Alameda CA 94502 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-05-07 | 11,546 | $5.82 | 20,067 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-05-07 | 20,000 | $3.38 | 40,067 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-05-07 | 31,546 | $25.02 | 8,521 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option (right to buy) | Disposition | 2020-05-07 | 11,546 | $0.00 | 11,546 | $5.82 |
| Common Stock | Option (right to buy) | Disposition | 2020-05-07 | 20,000 | $0.00 | 20,000 | $3.38 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2013-12-06 | 2020-12-05 | No | 4 | M | Direct |
| 20,000 | 2014-05-29 | 2021-05-28 | No | 4 | M | Direct |
Footnotes
- The option, representing the right to purchase a total of 43,546 shares of Exelixis, Inc. common stock, became fully exercisable on December 6, 2013.
- The option, representing the right to purchase a total of 40,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 29, 2014.
Billionaire Hedge Funds
